Low Anterior Resection Syndrome and Rectal Irrigation Study (LARRIS)

January 28, 2020 updated by: Cardiff and Vale University Health Board
Prospective study assessing treatment acceptability and the impact of rectal irrigation on patients with low anterior resection syndrome (LARS) in terms of quality of life and bowel function.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aims: To assess if rectal irrigation improves patient symptoms and quality of life in patients with LARS and to see if the treatment is acceptable to patients.

Methods: This is a mixed methods evaluation study on functional outcomes in patients who have undergone anterior resection for rectal neoplasia and who have had bowel continuity restored between Jan 2009 and Jan 2014. Those patients deemed to have LARS who consent to participation in the study will be offered rectal irrigation.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cardiff, United Kingdom, CF14 4XW
        • University Hospital of Wales

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who have undergone anterior resection for rectal neoplasia, patients who have had restored bowel continuity
  • LARS score of >20 (defined LARS syndrome)
  • patients > 18 years of age.

Exclusion Criteria:

  • previous use of rectal irrigation
  • patients who are unable to give informed consent
  • patients who are not physically capable of performing the treatment in their home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Treatment
Peristeen given
rectal irrigation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF12
Time Frame: pre intervention and 6 months post
quality of life
pre intervention and 6 months post

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EORTC
Time Frame: pre intervention and 6 months post
quality of life
pre intervention and 6 months post
Low anterior resection score
Time Frame: pre intervention and 6 months post
bowel function
pre intervention and 6 months post
St Marks Faecal incontinence score
Time Frame: pre intervention and 6 months post
bowel function
pre intervention and 6 months post
treatment acceptability questionnaire
Time Frame: post training for treatment and 6 months post treatment
post training for treatment and 6 months post treatment

Other Outcome Measures

Outcome Measure
Time Frame
qualitative interviews
Time Frame: after 6 months treatment or drop out from treatment group
after 6 months treatment or drop out from treatment group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

February 10, 2015

First Submitted That Met QC Criteria

January 28, 2020

First Posted (Actual)

January 29, 2020

Study Record Updates

Last Update Posted (Actual)

January 29, 2020

Last Update Submitted That Met QC Criteria

January 28, 2020

Last Verified

February 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIHR/UKCRN Portfolio ID: 18113

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Resection Syndrome

Clinical Trials on Peristeen

3
Subscribe